Jazz Pharmaceuticals Denmark ApS — Credit Rating and Financial Key Figures
CVR number: 39791447
Kampmannsgade 2, 1604 København V
nordicinfo@jazzpharma.com
www.jazzpharma.com
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 7 280.48 | 16 469.48 | 30 364.24 | 30 364.24 | 31 787.84 |
| Employee benefit expenses | -7 644.37 | -14 301.58 | -26 976.65 | -26 976.65 | -29 546.06 |
| EBIT | - 363.90 | 2 167.90 | 3 387.59 | 3 387.59 | 2 241.78 |
| Other financial income | 29.02 | ||||
| Other financial expenses | - 258.08 | - 333.29 | -1 408.77 | -1 408.77 | - 654.89 |
| Pre-tax profit | - 621.98 | 1 834.61 | 1 978.82 | 1 978.82 | 1 615.91 |
| Income taxes | 138.30 | - 294.11 | -5.88 | -5.88 | -1 020.73 |
| Net earnings | - 483.68 | 1 540.51 | 1 972.94 | 1 972.94 | 595.18 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 7 129.24 | 8 167.45 | 8 167.45 | 5 786.11 | |
| Inventories total | 7 129.24 | 8 167.45 | 8 167.45 | 5 786.11 | |
| Current trade debtors | 7 687.71 | 7 298.23 | 7 298.23 | 10 931.19 | |
| Current amounts owed by group member comp. | 6 591.39 | 3 499.25 | 8 198.97 | 8 198.97 | 10 046.81 |
| Prepayments and accrued income | 266.58 | 266.58 | 893.94 | ||
| Current other receivables | 148.88 | 1 693.84 | 1 134.35 | 1 134.35 | 2 024.12 |
| Current deferred tax assets | 261.30 | 922.40 | 966.11 | 966.11 | 741.78 |
| Short term receivables total | 7 001.57 | 13 803.20 | 17 864.23 | 17 864.23 | 24 637.84 |
| Cash and bank deposits | 2 501.85 | 1 852.82 | 1 447.41 | 1 447.41 | 5 657.45 |
| Cash and cash equivalents | 2 501.85 | 1 852.82 | 1 447.41 | 1 447.41 | 5 657.45 |
| Balance sheet total (assets) | 9 503.42 | 22 785.26 | 27 479.09 | 27 479.09 | 36 081.40 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | 6 521.70 | 6 038.02 | 8 138.79 | 8 138.79 | 10 111.72 |
| Profit of the financial year | - 483.68 | 1 540.51 | 1 972.94 | 1 972.94 | 595.18 |
| Shareholders equity total | 6 088.02 | 7 628.52 | 10 161.72 | 10 161.72 | 10 756.90 |
| Non-current liabilities total | |||||
| Current trade creditors | 876.88 | 2 042.12 | 2 911.23 | 2 911.23 | 4 982.59 |
| Current owed to group member | 7 636.83 | 9 224.95 | 9 224.95 | 12 324.49 | |
| Short-term deferred tax liabilities | 98.88 | ||||
| Other non-interest bearing current liabilities | 2 538.52 | 5 477.79 | 5 181.19 | 5 181.19 | 7 918.54 |
| Current liabilities total | 3 415.40 | 15 156.74 | 17 317.37 | 17 317.37 | 25 324.50 |
| Balance sheet total (liabilities) | 9 503.42 | 22 785.26 | 27 479.09 | 27 479.09 | 36 081.40 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.